Back to MW MARSHALL WACE, LLP
AMLX
Showing 4 of 13 quarters
Position history for MWMARSHALL WACE, LLP's holdings in AMYLYX PHARMACEUTICALS INC
No. Marshall Wace exited its AMLX (Amylyx Pharmaceuticals) position in Q2 2025. Its Q1 2025 13F listed 247,275 shares worth $875,353. Marshall Wace already held AMLX in its Q1 2022 13F, the earliest on record, and held it in 10 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$920,114
Total Shares Change
-283,986
Quarter-by-Quarter History